Incyte ($INCY) announced an update on their ongoing clinical study. Study Overview Incyte’s new Phase 3 trial, titled “A Randomized, Double-Blind, ...

James Van Der Beek’s stage 3 colorectal cancer fight will be documented in an upcoming interview on the “Today” show. “Today” ...

In patients with stage II-III rectal cancer, non-operative management after a clinical complete response to neoadjuvant ...

A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks. The service ...

PHILADELPHIA (WPVI) -- There is a clinical trial going on that hopes to change the way patients with early-stage colorectal cancer are treated. Fox Chase Cancer Center is investigating a method ...

Five years after being diagnosed with stage 4 colorectal cancer at 28, Joe Faratzis is reflecting on the six red flags that signaled he was struggling with a serious disease. “I put these symptoms off ...

She was shocked to be diagnosed with rectal cancer at 29 and had her reproductive organs temporarily moved out of her pelvis ...

Colorectal Surgeon Dr. Julio Garcia-Aguilar, MD, PhD (seated) with nurse Kieran Kelleher BSN-RN. Dr. Garcia-Aguilar and the colorectal service at MSK are experts at the watch and wait approach to ...

Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing ...

CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that FRUZAQLATM (fruquintinib capsules) will now be reimbursed by ...